Calevia Inc. to Develop Graphene-based, Non-Invasive Cancer Eradication Therapies in Partnership with Grafoid Inc. and ProScan Rx Pharma Inc. 0

MONTREAL, QUEBEC — (Marketwired) — 09/05/13 — ProScanRxPharma Inc. and Grafoid Inc announced today the formation of Calevia Inc., an entirely new cancer therapeutic nanotechnology platform for the precise targeting and thermal eradication of solid tumors.Calevia intends to combine ProScan-s cellular antibody targeting technologies with MesoGrafXide graphene supplied by Grafoid Inc. to eradicate cancerous cells in a non-invasive manner.Mesograf Xide is a unique, functionalized, photoresponsi